This topic contains a solution. Click here to go to the answer

Author Question: In the case study regarding one-trial learning, what was a potential methodological problem which ... (Read 46 times)

Evvie72

  • Hero Member
  • *****
  • Posts: 519
In the case study regarding one-trial learning, what was a potential methodological problem which may have existed within the design of the experiment?
 
  A) The first group may have received the harder pairs of nonsense syllables
  B) The second group may have received the easier pairs of nonsense syllables
  C) The first group may have received the easier pairs of the nonsense
  syllables
  D) The second group was a control group, not an experimental group

Question 2

Why is it important that all treatment groups are approximately equal regarding a variety of traits?
 
  A) So the results are attributable to the subject variables
  B) So the results are attributable to the independent variable
  C) So the results are attributable to the various traits of the participants
  D) So the results are understandable when conducting statistical analyses



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

CourtneyCNorton

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

C

Answer to Question 2

B




Evvie72

  • Member
  • Posts: 519
Reply 2 on: Jun 20, 2018
YES! Correct, THANKS for helping me on my review


31809pancho

  • Member
  • Posts: 317
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

Famous people who died from poisoning or drug overdose include, Adolf Hitler, Socrates, Juan Ponce de Leon, Marilyn Monroe, Judy Garland, and John Belushi.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library